Cleveland Clinic's 2020 Multidisciplinary Head and Neck Cancer Update

 

Cleveland Clinic's 2020 Multidisciplinary Head and Neck Cancer Update
Avatar

To De-intensify or Not in HPV+ Oropharyngeal Cancer - Lessons Learned from RTOG Trials: Radiotherapy + Cetuximab Is Inferior to Radiotherapy + Cisplatin

By Cleveland Clinic's 2020 Multidisciplinary Head and Neck Cancer Update FEATURING David Adelstein
By Cleveland Clinic's 2020 Multidisciplinary Head and Neck Cancer Update FEATURING David Adelstein
544 views
March 17, 2020
0 Comments
Login to view comments. Click here to Login
HPV/Oropharynx/Re-treatment/Personalized Radiotherapy/Value-based Care
16:32
Cleveland Clinic's 2020 Multidisciplinary Head and Neck Cancer Update

To De-intensify or Not in HPV+ Oropharyngeal Cancer - Lessons Learne…

Feat. D. Adelstein
10:46
Cleveland Clinic's 2020 Multidisciplinary Head and Neck Cancer Update

To De-intensification in HPV+ Oropharyngeal Cancer: For Induction Ch…

Feat. D. Adelstein
05:54
Cleveland Clinic's 2020 Multidisciplinary Head and Neck Cancer Update

HPV+ Oropharyngeal Cancer: HPV+ as a Prognostic Factor, Risk Stratif…

Feat. J. Greskovich
17:50
Cleveland Clinic's 2020 Multidisciplinary Head and Neck Cancer Update

Is Dose De-escalated Radiation Ready for Prime Time in Favorable HPV…

Feat. J. Greskovich
17:54
Cleveland Clinic's 2020 Multidisciplinary Head and Neck Cancer Update

Patient Selection for Transoral Robotic (TORS) and Laser Surgery for…

Feat. J. Scharpf
21:08
Cleveland Clinic's 2020 Multidisciplinary Head and Neck Cancer Update

The Future of Radiation Therapy (FORT) Project: Creating Personalize…

Feat. L. Harrison
28:50
Cleveland Clinic's 2020 Multidisciplinary Head and Neck Cancer Update

Total Cost of Care and Advanced Alternative Payment Models

Feat. R. Lorenz
22:36
Cleveland Clinic's 2020 Multidisciplinary Head and Neck Cancer Update

Case Based Discussion Panel on Oropharyngeal Cancer: De-Intensificat…

Feat. J. Scharpf, L. Harrison, D. Adelstein, J. Geiger, J. Greskovich